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Abstract
Background: The intense sweeteners currently authorised in Europe comprise ten compounds of various chemical
natures. Their overall use has sharply risen in the last 20 years. These compounds are mainly used to formulate
reduced-calorie products while maintaining sweetness.
Methods: This extensive analysis of the literature reviews the data currently available on the potential nutritional
benefits and risks related to the consumption of products containing intense sweeteners.
Results and Conclusions: Regarding nutritional benefits, the available studies, while numerous, do not provide
proof that the consumption of artificial sweeteners as sugar substitutes is beneficial in terms of weight
management, blood glucose regulation in diabetic subjects or the incidence of type 2 diabetes. Regarding
nutritional risks (incidence of type 2 diabetes, habituation to sweetness in adults, cancers, etc.), it is not possible
based on the available data to establish a link between the occurrence of these risks and the consumption of
artificial sweeteners. However, some studies underline the need to improve knowledge of the links between
intense sweeteners consumption and certain risks.
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Background
The term 'Intense sweeteners' (IS) refers to various sub-
stances of plant origin or obtained by chemical synthesis,
used in the food industry for their high sweetening
power and their low caloric value. The intense sweet-
eners currently authorised in Europe comprise ten com-
pounds of various chemical natures.
They are used in the formulation of foods and bever-
ages, essentially for their sweetening role but also for their
technological properties (stabilisers, texturisers). Their
sweetening power is a hundred (e.g. acesulfame K, aspar-
tame) to several thousand (e.g. neotame) times higher
than that of sucrose. Their overall use has sharply risen in
the last 20 years. These compounds are mainly used to
formulate reduced-calorie products while maintaining
sweetness. Their lower calorie content suggests a direct
link to weight management for consumers. However, no
claim- related to the effects of IS on weight management
have been authorised.
This extensive analysis of the literature reviews the
data currently available on the potential nutritional ben-
efits and risks related to the consumption of products
containing IS, particularly since nutritional benefits were
not examined in the context of the initial authorisation
issued under Regulation (EU) No 257/2010.
Methods
The substances covered in this assessment are the IS
currently authorised in Europe, after scientific review:
aspartame [1], acesulfame potassium (K) [2], cyclamic
acid and its salts [3], steviol glycosides [4], neohesperidin
dihydrochalcone [5], neotame [6], saccharine and its
salts [7], sucralose [8], aspartame-acesulfame salt [2] and
thaumatin [5].
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The search strategy aimed to find both published and
unpublished studies. A three-step search strategy was
utilised in this review. An initial search of Medline
(Table 1), Cochrane Database of Systematic Reviews and
Psychinfo was undertaken, followed by analysis of the
text words contained in the title and abstract, and of the
index terms used to describe the article. A second search
using all identified keywords and index terms diet was
then undertaken across all included databases. Thirdly,
the reference list of all identified articles was searched
for additional studies. No language restriction was ap-
plied. Moreover, food industries and consumer associa-
tions were contacted to know if they were aware of
unpublished studies.
Types of studies were broad and unrestrictive to
capture as much data as possible. Meta-analysis, rando-
mised controlled, quasi experimental, cohort, case-
control and cross-sectional studies were accepted. In
vitro, ex vivo, and animals studies have been excluded.
Whatever its design and quality, a single study is never
able to establish the causality between the exposure and
the disease, in this case between IS consumption and its
effects on health. In our review, we used part of Hill’s
criteria of causation to assist in the assessment of the
causal relationships. Indeed, a modified version of the
Bradford Hill criteria was used to evaluate the evidence
of a causal relationship between IS consumption and
health outcomes. As a matter of fact, the following eight
criteria, considered as the most important to answer our
questions, were used in our review: strength, consistency,
temporality, coherence, experiment, plausibility, analogy
and biological gradient. One criterion, the specificity, was
omitted because considered as nonspecific to our various
outcomes. It should be pointed that none of these criteria
alone is sufficient to establish causality and that no sys-
tematic algorithm was used. The final interpretation of the
causality was based on experts’ judgment based on all ana-
lysed data.
Results
The exhaustive review included 10,989 manuscripts
(9,965 in English and 1024 in non-English languages).
Out of them, 9,373 were excluded after a reading of the
title and the abstract. Consequently, 1,616 full-text man-
uscripts have been extensively reviewed of which 383 (all
in English) have been considered of interest for the topic
of benefits and risks related to IS. For this review how-
ever, only the most relevant ones have been quoted,
mainly based on their methodology, novelty and ori-
ginality. Among these studies, 30.1 % were funded by
the industry, 56.3 % by non-profit organisations, and
the others did not report funding sources. However,
we did not consider differently studies based the
funding source.
Table 1 Search strategy in Medline
1. Sweetening agent*.mp
2. Sweetener*.mp
3. Sweetened.mp
4. Aspartam*.mp
5. Aspartam*-acesulfame salt*.mp
6. Acesulfam*.mp
7. Acesulfame potatium.mp
8. Acesulphame.mp
9. Cyclamat*.mp
10. Stevia*.mp
11. Steviol*.mp
12. Neohesperidin dihydrochalcone.mp
13. Neotam*.mp
14. Saccharin*.mp
15. Sucralose*.mp
16. Thaumatin*.mp
17. Low calori*.mp
18. Sugar substitue*.mp
19. Diet* drink*.mp
20. Diet* refreshement*.mp
21. Diet* food*.mp
22. Diet* chocolat*.mp
23. Diet* yoghourt*.mp
24. Diet* milk*.mp
25. Diet* beverage*.mp
26. Diet* jam*.mp
27. Diet* marmalade*.mp
28. Diet* candy*.mp
29 Diet* cookie*.mp
30. Diet* biscuit*.mp
31. Diet* cracker*.mp
32. Diet* eat*.mp
33. Diet* cuisine*.mp
34. Diet* cook*mp
35. Diet* meat.mp
36. Diet* nutriment*.mp
37. Diet* nutrition*.mp
38. Diet*menu*.mp
39. Diet* dish*.mp
40. Diet* drinkable*.mp
41. Diet* drinking*.mp
42. Diet* juice*.mp
43. Or/1-16
44. Or/17-42
45. Or/43-44
46. Limit 45 to humans
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Effects on eating behaviour and taste preferences
IS are often consumed as sugar substitutes, particularly
in beverages, in order to satisfy a desire for sweetness
while avoiding energy intake from sugars. The expert ap-
praisal assessed whether there were metabolic conse-
quences of this separation of sweetness and calorie
intake, particularly in terms of body's ability to associate
a taste with an energy value and therefore regulate its
energy balance, and also in terms of consequences of IS
consumption on appetite for sweetness and the con-
sumption of sweet products.
Data in adults
A meta-analysis covering studies undertaken before
2006 along with around ten randomised experimental
studies were identified to address these points. The
meta-analysis of 15 randomised experimental studies [9]
assessed the effects of aspartame consumed alone or with
other (unspecified) IS on food and energy intake during
the course of a day in adults. These measurements
covered a limited number of subjects (less than 30) and
highly variable time periods of a few days to 16 weeks.
The main inclusion criterion for studies in this meta-
analysis was the measurement of food intakes for at least
24 hours, to assess the full extent of any compensatory
effects of the various meals consumed over the day. The
authors conclude that consuming aspartame as a sugar
substitute results in a decrease of daily energy intake by
220 Kcal on average. Moreover, the authors indicate that
this substitution may be more efficient in beverages than
in solid foods, since the energy supplied by liquids leads to
less satiety than that supplied by solid foods. In fact, the
estimated compensation rate is thought to be lower for
sugars consumed in liquid form than in solid form [10].
Therefore, according to these authors, the reduction in
energy intake due to the replacement of sugar with sweet-
eners is greater with artificially sweetened beverages than
with artificially sweetened solid foods. However, the con-
clusions of this meta-analysis should be treated with
caution, due to several methodological limitations, par-
ticularly a lack of essential information on the study selec-
tion process, the assessment of their quality and the
statistics applied to assess the heterogeneity of the data
taken into account. Other experimental studies (that were
not included in the meta-analysis since they covered pe-
riods of less than 24 hours) analysed the effects of IS on
appetite and food intake. These studies used an IS preload
approximately one hour before a meal, generally in bever-
age form (rarely in solid form, i.e. in a food), and mea-
sured food intake and calorie intake during the next meal.
All of these studies showed that irrespective of the nature
of the tested IS, a preload reduced the sensation of hunger
and the desire to eat, with a maximum effect immedi-
ately after its consumption. However, this effect tended
to disappear before the start of the meal, which explains
why most studies did not observe reduced food intake
during the meal after the preload. Regarding food pref-
erences, several studies assessed the effect of IS on the
perception of sweetness (gustatory stimuli) and/or taste
preferences for foods. Several studies showed that pref-
erence for a sweet food was independent of the sweet-
ening agent (i.e. no difference between an IS and
sucrose), but their results differed as to the repercus-
sions of this preference on consumption of this food.
However, these studies had extremely variable protocols
and objectives, to the extent that it is difficult to com-
pare their results and draw an overall conclusion on
the effect of IS on food preferences.
Overall, based on studies dealing with occasional ex-
posure to an IS before a meal, it is not possible to infer
the effect of regular IS consumption on sweetness ha-
bituation or increased cravings for sweetened products.
Most experimental studies show that the occasional con-
sumption of IS before or during a meal has no effect on
food intake or energy intake during the next meal. Occa-
sional IS consumption before a meal reduces the sensa-
tion of hunger and the desire to eat, just like caloric
sweeteners, but this effect is temporary and disappears
before the start of the meal. In most cases, the use of IS
as sugar substitutes results in a decrease in short-term
energy intake due to their low calorie content and the
lack of compensation. However, the available data cover
insufficient time periods to guarantee the maintenance
of this effect over the medium or long term.
Data in children
Preference for sweetness is innate. It is strong at birth and
then tends to decrease. However, it seems to be main-
tained by the repeated consumption of sweetened foods
or beverages during early childhood [11]. A study [12]
showed that adding aspartame or sucrose to milk favoured
its consumption. Moreover, the work of Birch and their
collaborators revealed that children preferred flavours as-
sociated with calorie intake, suggesting that sweetness it-
self is not sufficient to generate food preferences, and that
energy density, just as much as (or even more than) sweet-
ness, can determine food preferences [13, 14]. However,
there are no data showing whether IS have a specific ef-
fect, in relation to caloric sweeteners, on the development
of taste and food preferences. A study compared the ef-
fects of consuming 250 mL daily of artificially sweetened
beverages vs sugar-sweetened beverages on the satiety
and desire to eat of children aged seven to 11 years
for 18 months [15]. The level of satiety was the same,
irrespective of the beverage consumed.
In conclusion, based on the available studies, it is not
possible to determine whether IS consumed during
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early childhood have a specific effect on the develop-
ment of taste and food preferences or on the short-
and medium-term regulation of food intake.
Effects on body weight and composition
IS are commonly used by consumers as sugar substitutes
as part of weight-loss diets or to control energy intake
and prevent weight gain.
Data in adults
Two meta-analysis (Table 2) [9, 16], a systematic review
[17] and several original articles [18–29]examined the
relationship between IS consumption and changes in
body composition and weight. A meta-analysis [30] took
into account observational studies (with nine articles in-
cluded) and randomised controlled trials (RCTs, with 15
articles included) in adults and children. The section on
observational studies showed no relationship between IS
consumption and changes in body weight or fat mass
but showed a slight increase in BMI (+0.03 kg/m2 on
average). The section on RCTs showed that replacing
sugars with IS in sweet products resulted in moderate
weight loss (with an estimated average effect of 0.8 kg)
and a decrease in BMI (-0.24 kg/m2 on average) for time
periods ranging from three weeks to 18 months. This
meta-analysis, of good methodological quality, highlights
the extreme variability of results from studies with a
similar design (whether RCT or observational) and the
differences in results between observational studies and
RCTs. In the meta-analysis by De la Hunty [9], eight
studies on very heterogeneous populations (people with
energy restrictions and unrestricted diets, normal-weight
and obese people, in normal living conditions and in
metabolic chambers) were included. According to the
authors, the effect of IS on weight loss is significant.
They extrapolate the theoretical reduction of 220 kcal/
day related to the replacement of sugars with aspartame
over the long term, and by postulating its maintenance
over time, calculate that this reduction could result in
weight loss of 0.2 kg per week. However, the methodo-
logical weaknesses of this meta-analysis has to be
emphasised, particularly the lack of essential information
related to the study selection process and the statistics
applied to assess heterogeneity. The systematic review
by Wiebe et al. (2011) cites two intervention studies
comparing the effects of artificially sweetened drinks
and sugar-sweetened drinks on BMI [31,32]. These stud-
ies, focusing on different populations (normal-weight
women in one and overweight women in the other), had
different results (no effect in normal-weight women, re-
duced weight in overweight women). Five other rando-
mised controlled trials [21, 24, 25, 27, 29] were
identified. They were all undertaken in overweight sub-
jects and the majority focused on very small populations
(between 20 and 50 subjects). Two demonstrated mod-
est weight loss of 1.2 and 1.5 kg on average, but the
other three, including the one with the largest study
population (n = 318), did not show any effects on weight
loss related to the consumption of artificially sweetened
beverages compared to the consumption of sugar-
sweetened beverages or water. There are also seven pro-
spective observational epidemiological studies with
highly heterogeneous results. One study did not show
any association between IS consumption and changes in
body composition [23]; four studies reported a positive
association, i.e. a significantly higher body weight or
waist size in IS consumers [18–20,28]; and two studies
reported a negative association [22, 26].
In conclusion, observational and intervention studies re-
port contradictory associations between IS consumption
Table 2 methodology of the meta-analyses on the effect of intense sweeteners on body composition.
First Author,
year of publication
(reference)
Search date Database
used
Population Study design Main findings Heterogeneity Publication bias
de la Hunty,
2006 (ref 9)
Not clear Not clear Healthy adults RCT (N = 9) Non-significant effect size
of 0.221 (0.000 to 0.443)
standard deviation of
weight loss
Not assessed Not assessed
Miller, 2014
(ref 16)
16 September
2013
PubMed
+manual
search
Healthy adults
and children
RCT (N = 15)
Prospective
study (N = 9)
1. RCT: No evidence of publication
bias (Egger’s regression test)
- on weight: -0.80 kg
(–1.17 to –0.43)
I2 61 %
- on body mass index:
–0.24 kg/m2 (–0.41 to –0.07)
I2 0 %
2. Prospective studies
- on weight: 0.02 kg
(–0.01 to –0.06)
I2 92 %
- on body mass index:
0.03 kg/m2 (0.01 to 0.06)
I2 53 %
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and weight loss. Therefore, no conclusion can be drawn as
to the long-term effect of replacing caloric sweeteners
with IS on the weight of regular adult consumers of sweet
products.
Data in children
Four RCT studies focusing on the relationship between
IS consumption and body composition were identified.
In three of these studies, changes in weight and BMI did
not differ between IS consumers and non-consumers
[33–35]. These studies focused on overweight or obese
children and had methodological limitations. The fourth
study, of good methodological quality, examined the
effects of consuming 250 mL/day of an artificially sweet-
ened drink, compared to the same amount of sugar-
sweetened drink, in 641 normal-weight children (aged
four to 12 years), who were regular consumers of sugar-
sweetened drinks, for 18 months [36]. This study showed
a significant decrease in the BMI z-score (the most rele-
vant criterion to assess changes in corpulence in growing
children) in the group that consumed artificially sweet-
ened drinks. The change in body weight between the two
groups differed by 1 kg on average. Of the seven prospect-
ive epidemiological studies in children, five [37, 38] ob-
served a positive relationship between IS consumption
(primarily in beverage form) and weight over time, while
two [37] did not find any relationship. To explain these
findings, the authors of these studies assumed that sub-
jects 'at risk for weight gain' or with less healthy food pro-
files were those who consumed the most IS in order to
reduce their energy intake.
Most of the prospective observational studies under-
taken in children show that IS use is paradoxically asso-
ciated with weight gain, although the causality of this
relationship has not been established. The four available
controlled trials showed conflicting results but none re-
ported weight gain. No conclusions can be drawn from
all of these studies as to the significance of IS for weight
management in children and adolescents.
Effects on blood glucose and type 2 diabetes
This section presents data on the effects of IS consumption
on glucose homeostasis and risk of diabetes, in healthy
subjects, type 1 diabetics and type 2 diabetics Thirty-one
clinical trials and two reviews assessed the short-term ef-
fects (less than one week) of IS consumption on glucose
homeostasis. To date, the data on the long-term risk of de-
veloping diabetes are still limited and have been taken from
seven observational epidemiological studies.
Effects on glucose homeostasis
Regarding the acute effects (i.e. less than 24 hrs.), the
available studies did not show any effects related to
the consumption of aspartame on an empty stomach
[39–44], saccharine [45] or sucralose [46, 47] on
blood glucose and insulin levels. Other studies assessed
acute effects of IS on post-prandial glycaemic parameters
after a test meal [48–52]. These studies generally showed
that consuming IS before a test meal did not modify
post-prandial glycaemic and insulin responses com-
pared to a placebo, and reduced these responses com-
pared to a sucrose preload. These effects were reported
irrespective of the tested IS (aspartame, stevia extract,
sucralose, beverage containing acesulfame K and su-
cralose). It should also be noted that the parameters of
these studies were highly variable with differences in
the composition of test meals, the time between the
preload and the meal, the studied subject groups (age,
sex, healthy overweight or obese subjects) and the pre-
load form (solid or liquid). Several studies also showed
that consuming IS before a meal resulted in increased
secretion of GLP1 (Glucagon-like peptide), a gastro-
intestinal hormone that usually increases insulin secre-
tion, slows down gastric emptying and reduces gluca-
gon secretion [53]. This increase in GLP1 may be
induced by IS activating sweetness receptors, as sug-
gested by data in rats [54].
When considering short- and medium-term effects, sev-
eral studies assessed the effect of regular IS intake (one to
three times per day, for a few days to several weeks), in
capsule form or in beverages, on maintaining blood sugar
control (glucose and insulin concentrations measured
after a night of fasting, glycated haemoglobin HbA1c). For
type 2 diabetics, the consumption of sucralose [55] or as-
partame [56–58] for periods of up to 18 weeks did not
change fasting glucose levels) compared to sucrose or a
placebo. Furthermore, fasting plasma glucose and insulin,
and HOMA-IR (insulin sensitivity calculated from the
HOMA index) were not modified in non-diabetic obese
subjects who had consumed a beverage sweetened with
aspartame for six months compared to groups who had
consumed sugar-sweetened drinks, water or milk [21].
Other studies covering unspecified IS compared to su-
crose in obese or overweight subjects [59] confirm these
results. Regarding stevia extracts, the data show either a
lack of effect on glucose control in healthy [59] or diabetic
[59] subjects or a slight significant decrease in blood glu-
cose levels in healthy subjects [59] or hypertensive sub-
jects [60].
Overall, the vast majority of studies do not show any
acute effects of IS intake on blood glucose or insulin
concentrations measured on an empty stomach or after
a test meal, in healthy subjects or in diabetics. Some
studies reported a modest increase in GLP-1 secretion,
but with no repercussions on insulin secretion or blood
glucose concentrations. IS consumption has no effect on
short- and medium-term blood glucose parameters in
healthy subjects or in diabetics.
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Effects on the risk of type 2 diabetes (T2D)
The seven observational studies dealing with IS con-
sumption and the incidence of T2D showed diverging
results. Four cohort studies of good quality (three under-
taken in North American populations and one in a
European population), over periods of nine to 24 years,
did not show any relationship between the consumption
of artificially sweetened beverages and the risk of devel-
oping T2D after adjustment for BMI and energy intake
of subjects [61–63, 26]. Three other cohort studies sug-
gested a positive association between the consumption
of artificially sweetened beverages and the incidence of
T2D [64–66]. Among them a French study, [64], showed
that the incidence of T2D was significantly higher (HR
(95 % CI) 2.21 [1.56-3.14]) in the group of women con-
suming the largest amounts of artificially sweetened bev-
erages (over 600 mL per week) who were monitored for
14 years, with a linear and dose-dependent relationship.
The second study, undertaken in the United States for
seven years, reported an increase in the incidence of
T2D in subjects consuming more than one artificially
sweetened beverage per day in a model with adjustment
for the primary confounding factors (HR (95 % CI) 1.67
[1.27–2.20]. The third study, which reported an in-
creased incidence of T2D in subjects consuming more
than one artificially sweetened beverage per week (HR
(95 % CI) 1.70 [1.13–2.55], focused on a limited-sized
Japanese population not representative of the general
population, monitored for seven years. It is important to
underline the heterogeneity of these data, particularly in
terms of the characteristics of the populations and the
monitoring periods (from seven to 24 years). Further-
more, in these studies, the consumption of artificially
sweetened beverages was recorded when the subjects
were first included, often through self-administered fre-
quency questionnaires, with no updating of dietary data
over time.
In conclusion, the long-term epidemiological studies
on the risk of developing T2D show heterogeneous re-
sults, but the most robust studies do not report any
effects.
Other effects
Effects on lipid parameters
Of the 20 randomised controlled experimental studies
analysed, the majority focused on aspartame or stevia ex-
tracts. Compared to a placebo, aspartame consumption
had no effects on triglycerides or cholesterol concentra-
tions (either total, HDL, LDL or VLDL cholesterol) in
various populations (healthy, T2D and overweight sub-
jects) for periods ranging from 13 to 28 weeks. Compared
to a caloric sweetener (sucrose, glucose or fructose), of the
five identified studies, two showed a modest significant
improvement in lipid profile (TG and/or total cholesterol)
in the group that received aspartame, still with no differ-
ences compared to the placebo. Three studies, two in T2D
patients, assessed the effect of stevia extracts on lipid pa-
rameters and showed no differences compared to a pla-
cebo. Studies using other types of IS (cyclamate, sucralose,
IS mixture or unspecified IS) also showed no effects on
the assessed lipid parameters. Of the four identified cohort
studies, most showed no effects on lipid parameters re-
lated to the consumption of artificially sweetened bever-
ages. A single study reported a positive association
between the consumption of these beverages and an in-
crease in TG concentrations associated with a lowering of
HDLc [67].
In conclusion, the majority of observational studies
showed no effects on lipid profile related to IS. Two
studies reported that replacing sugars with aspartame re-
duced plasma triglyceride concentrations but the data
are too limited to conclude that IS have a beneficial
effect on lipid profile.
Effects on pre-term deliveries
Two epidemiological studies are available. In the first
[68], a dose-effect relationship was observed, which
meant that the risk of pre-term delivery was higher
in the heaviest consumers of artificially sweetened
beverages (OR (95 % CI) 1.38 [1.15-1.65] for ≥ 1 serv-
ing of artificially sweetened carbonated soft drinks/d).
In addition to this Danish study, another study, with
a similar methodology and including over 60,000
pregnant women, suggested that the consumption of
artificially sweetened beverages and sugar-sweetened
beverages was associated with an increased risk of
spontaneous or induced pre-term delivery (OR (95 % CI)
1.11 [1.00-1.24] for ≥ 1 serving of artificially sweetened soft
drinks/d). However, although the association was stronger
for sugar-sweetened beverages, the authors concluded that
they could not determine whether this risk was caused by
the effects of these beverages or by other associated diet-
ary or socio-economic factors [69].
Based on the available data, it is not possible to iden-
tify any benefits or draw any conclusions regarding the
risk related to the consumption of intense sweeteners
during pregnancy, in terms of maternal health, obstet-
rical parameters or newborn health.
Effects on cancer
The relationship between IS consumption and cancer in
humans was assessed in 55 scientific studies. Thirty-nine
of these studies involved the urinary tract and 32 fo-
cused exclusively on bladder cancer. The other studies
assessed the relationship between IS consumption and
the risk of brain cancer (four studies), digestive system
cancer (six studies) or other cancers (five studies).
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Except in the studies focusing on bladder cancer, the IS
in question were not identified by the authors. The rela-
tionship between saccharine consumption and bladder
cancer was the most commonly studied, given that data
were available in rodents [70]. The results of studies in
humans are conflicting. Based on the analysis of data in
humans, it is not possible to determine a relationship
(whether for saccharine or for the other studied IS),
since the studies did not adjust their results for major
confounding factors such as exposure to chemical pol-
lutants. Regarding kidney, brain, digestive system and
breast cancers, the data are more limited and do not
show any relationship with IS consumption. A recent
cohort study examining the risk of lymphoma and leu-
kaemia suggested an increased risk of non-Hodgkin
lymphomas and multiple myelomas in males consuming
more than one serving (355 mL) per day of artificially
sweetened beverages and in the heaviest consumers of
aspartame (as a table-top sweetener and in beverages)
compared to non-consumers [71]. No significant associ-
ation was reported in women. The authors specified that
due to the differences in the results by sex, the results
should be interpreted with caution. Moreover, this study
did not take into account exposure to chemical pollut-
ants as a confounding factor. However, it is worth noting
that this study attempted to take into account, in its
statistical analysis, changes in the individual consump-
tion of artificial sweeteners over time, although little in-
formation is available regarding the methodology.
On the whole, the epidemiological studies do not show
any effects of IS consumption on cancer risk. Only one
recent study suggested a relationship between the con-
sumption of beverages containing IS and the occurrence
of non-Hodgkin lymphomas and myelomas, and add-
itional studies are required.
Neurological effects
Regarding the potential neurological effects of IS, only
aspartame has been studied. There are two studies in
healthy adults [72, 73]. No effects of aspartame on the
measured parameters (reaction time, headaches, hunger,
sedation, electroencephalographic parameters) were ob-
served. The study undertaken in epileptic subjects [74]
showed no statistically significant difference between as-
partame and the placebo on the incidence of epileptic
seizures. The four available studies on migraine subjects
[75–78] show conflicting results. However, no conclu-
sion can be drawn due to their poor methodological qual-
ity (no adjustment) and the subjective nature of the
measured effects (using non-validated self-questionnaires).
Regarding children, there are two studies, one in epileptic
children [79] and the other in hyperactive children [80],
showing no significant effects of aspartame.
Some studies with significant methodological limita-
tions suggested that aspartame consumption may be in-
volved in triggering epileptic seizures and migraines but
no conclusions can be drawn regarding the occurrence
of such a risk from the data as a whole.
Discussion and recommendations
The use and consumption of intense sweeteners have
risen sharply over the last twenty years, probably due to
concerns linked to the doubling of prevalence of over-
weight and obesity. While the potential risks of each in-
tense sweetener are assessed before their authorisation,
no general assessment of the overall nutritional risks
and benefits of these products has been conducted at
the European level up to now [81–83].
After an analysis of all of the scientific literature, it ap-
pears that, despite a large number of studies, the data
are insufficient to determine any long-term nutritional
benefits related to the consumption of products contain-
ing IS as sugar substitutes. The available data do not
show any risks related to IS consumption. However, due
to the limited number of studies, it is not possible to
rule out potential long-term risks related to IS consump-
tion in specific populations, particularly adult daily con-
sumers and children. It is important to note that before
their authorization to be on the market, the potential
risks of each intense sweetener are assessed and an ac-
ceptable Daily Intake (ADI) is set for each IS. Based on
several food surveys, an estimate of the dietary intakes
of the ISs currently used in various countries shows that
in all study populations (i.e. adults and children over the
age of three, pregnant women and young diabetics) and
irrespective of the IS taken into consideration, the mean
and 95th percentile intakes are lower than the ADIs.
The use of intense sweeteners as a substitute for sugar
in most cases engenders a short term reduction in cal-
oric intake due to the low calorie levels of these sub-
stances and the lack of compensation. However, the
available data cover insufficient time periods for guaran-
teeing that this effect is maintained in the long term.
Moreover, studies of weight control in adults and chil-
dren have reported conflicting associations. Certain ob-
servational studies show that intense sweetener use is
paradoxically associated with weight gain, although the
causality of this relationship has not been established.
The consumption of intense sweeteners was not
shown to have any beneficial effects on prevention of
type 2 diabetes; similarly, their regular consumption as a
sugar substitute does not appear to have any beneficial
effect on regulating blood glucose concentrations. For
the risks of developing cancer, type 2 diabetes, or prema-
ture births, the data available to date do not enable a
link to be established between onset of these risks and
the consumption of intense sweeteners. A few studies do
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however highlight the need to obtain further knowledge
on the link between intense sweeteners and certain risks
and in specific populations, particularly adults daily con-
sumers and children.
This review of the scientific literature revealed some gaps
that should be filled and areas of research that should be
explored. There were differences between the results of
randomised controlled trials and the results of observa-
tional studies. Furthermore, the studies assessing the effects
of replacing sugars with IS on eating behaviour or energy
intake were undertaken over the short term and should be
supplemented with long-term studies. Two types of add-
itional studies seem necessary to clear up these differences.
On the one hand, longer-term (at least one year) blind,
placebo-controlled intervention studies would shed further
light on the metabolic and physiological effects of IS. On
the other hand, intervention studies in which IS are con-
sciously consumed would help to understand potential
changes in eating behaviour related to the replacement of
sugars with IS in near-real-life conditions. There are also
very few data on the long-term impact of IS on food prefer-
ences. Therefore, it appears necessary to study the effects
of IS consumption on dietary choices. In most of the co-
hort studies, the consumption of artificially sweetened bev-
erages was reported only when the subjects were first
included, and subsequent consumption was not taken into
account. These studies assessed only the consumption of
artificially sweetened beverages, and not the total consump-
tion of artificial sweeteners. It is also difficult to distinguish
between the effects of the various IS consumed alone and
their effects when combined with other IS. Future cohort
studies should be capable of taking into account qualitative
and quantitative changes in the consumption of artificially
sweetened products and adapted dietary questionnaires, to
accurately and specifically assess IS consumption. Specific
populations such as pregnant women, children, diabetic
subjects and regular IS consumers have not been ad-
equately studied. It appears necessary to further study the
effects of IS in these populations. Likewise, it appears ne-
cessary to determine the repercussions of IS consumption
during the peri-natal phase on offspring (under the 'foetal
programming' assumption). Some data suggested that the
potential effects of IS on changes in weight or the incidence
of diabetes may vary depending on initial corpulence. Due
to the increasing prevalence of obesity, it appears necessary
to study potential interactions between corpulence and IS
consumption in terms of the risk of weight gain or diabetes.
At last, the literature on steviol glycosides is still sparse and
should be enhanced, particularly given the recent growth in
their use in beverages and foods.
Conclusions
No beneficial effects have been shown that provide grounds
to recommend regular IS consumption for adults or
children. Moreover, the available data do not show
the occurrence of risk in occasional consumers. How-
ever, based on the epidemiological data currently
available, it is not possible to completely rule out cer-
tain risks in the event of regular, prolonged consump-
tion. Therefore, for the general population, the overall
assessment of potential risks and benefits does not
justify the long-term use of IS as sugar substitutes,
particularly in beverages, which are their main vector.
Lastly, in a nutritional policy context in which one of
the main objectives is the reduction of sugar intake
in the general public, as pointed out by the 2015
WHO guidelines on sugar intake, this review points
out that no meaningful data exist that justify encour-
aging the substitution of sugars by intense sweeteners.
This objective of reduction of sugar intake levels
should be reached through a reduction in sweet tast-
ing foods in general at an early age. It should there-
fore be recommended that artificially-sweetened and
sugar-sweetened soft drinks shall not be consumed as
a replacement for water.
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